Skip Navigation

Masks are required inside all of our care facilities. We are vaccinating all eligible patients. Learn more:

Vaccines, Boosters & Additional Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Email Alerts

Find more COVID-19 testing locations on Maryland.gov.

Clinical Trials

Clinical trials are an important part of the Johns Hopkins Kimmel Cancer Center's treatment options. Every treatment available today started as  a clinical trial.

Clinical trials, also known as studies, offer new treatment options for cancer patients. There are many different kinds of clinical trials. Your oncologist can describe the studies that may be a fit for you.

Don't be afraid to ask questions! Our doctors and nurses understand that there is a lot to consider when making decisions about treatment including participating in a clinical trial. Our videos help explain clinical trials so you and your healthcare team can make the choice that's right for you.

 

Search Cancer Related Clinical Trials

PRISMM

Patient Response to Immunotherapy using Spliceosome Mutational Markers or PRISMM is a Johns Hopkins trial for patients with advanced breast cancer whose tumors have been sequenced and have a spliceosome mutation (SF3B1)

  

Clinical Trials Resources

back to top button